Thyroid and Parathyroid Tumors

November 18th, 2022 - November 18th, 2025
1.00 AMA PRA Category 1 Credit Hours
1.00 MOC Points


Today on MedNet21, we're going to discuss Thyroid and Parathyroid Tumors.

This webcast will cover thyroid nodules and the evaluation and management of nodules based on size and characteristics. The second half of the program will review hyperparathyroidism and both the NIH criteria for surgery and newer recommendations based on the latest research for management of hyperparathyroidism.

View Webcast Take Post-Test

Dates and Times

End Date: 11/18/2025


As a result of this educational activity, webcast participants will be able to:

  • Discuss management of thyroid nodules.
  • Determine need for parathyroidectomy in patients with primary hyperparathyroidism.

Webcasts Files

File Link

Thyroid and Parathyroid Tumors - 2


Thyroid and Parathyroid Tumors - 4


Thyroid and Parathyroid Tumors - 2 color


Disclosure Information for Planning Committee Members and Speakers



  • Dr. Priya Dedhia, MD


The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.